Quant Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • (-2.28%)Nav, as on 25-04-2025

  • Previous Nav

  • Net Change on 25-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty India Consumption - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 20.15 21.18 23.72 0.91 8,080.97
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 25.91 25.34 26.54 1.18 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 24.80 25.07 26.26 0.90 3,610.51
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 19.60 21.79 26.26 0.63 3,018.76
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 22.79 20.12 24.65 0.61 2,667.40

Fund Holdings as on 31-March-2025

  • Divi's Laboratories Limited

  • RPG Life Sciences Limited

  • Aster DM Healthcare Limited

  • IPCA Laboratories Ltd

  • Torrent Pharmaceuticals Ltd

  • Alivus Life Sciences

  • Zydus Lifesciences Limited

  • Aurobindo Pharma Limited

  • Reliance Industries Limited

  • Zydus Wellness Ltd

  • Pfizer Ltd

  • HFCL Limited

  • Sequent Scientific Limited

  • SMS Pharmaceuticals Limited

  • 91 Days Treasury Bill 24-Apr-2025

  • Suraksha Diagnostic Limited

  • Dr. Reddy's Laboratories Limited 24/04/2025

  • TREPS 02-Apr-2025 DEPO 10

  • Aurobindo Pharma Limited 24/04/2025

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Refineries

  • Consumer Food

  • Telecom-Infrastructure

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • Sov

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹369.93 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty India Consumption - TRI as secondary index.

The NAV of Quant Healthcare Fund ended down ₹-0.35(-2.28%)yesterday to ₹14.9551.

Among its top 3 holdings the fund has exposure to Divi's Laboratories Limited, and

The Quant Healthcare Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000